Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research Article: New Research, Disorders of the Nervous System

Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy

Gwen van der Wijk, Mojdeh Zamyadi, Signe Bray, Stefanie Hassel, Stephen R. Arnott, Benicio N. Frey, Sidney H. Kennedy, Andrew D. Davis, Geoffrey B. Hall, Raymond W. Lam, Roumen Milev, Daniel J. Müller, Sagar Parikh, Claudio Soares, Glenda M. Macqueen, Stephen C. Strother and Andrea B. Protzner
eNeuro 3 June 2024, ENEURO.0286-23.2024; https://doi.org/10.1523/ENEURO.0286-23.2024
Gwen van der Wijk
1University of Calgary, Department of Psychology, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mojdeh Zamyadi
2Rotman Research Institute, Baycrest Health Sciences, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Signe Bray
3Child and Adolescent Imaging Research Program, University of Calgary, Calgary, AB, Canada
4Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB, Canada
5Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada
6Department of Radiology, University of Calgary, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefanie Hassel
7University of Calgary, Cumming School of Medicine, Department of Psychiatry, Calgary, Canada
8Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen R. Arnott
2Rotman Research Institute, Baycrest Health Sciences, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benicio N. Frey
9Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada
10Mood Disorders Program and Women’s Health Concerns Clinic, St. Joseph’s Healthcare, Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sidney H. Kennedy
11Department of Psychiatry, University of Toronto, Toronto, Canada
12Institute of Medical Sciences, University of Toronto, Toronto, Canada
13Centre for Mental Health, University Health Network, Toronto, Canada
14Centre for Depression and Suicide Studies, Unity Health Toronto, Toronto, Canada
15Krembil Research Institute, Toronto Western Hospital, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew D. Davis
2Rotman Research Institute, Baycrest Health Sciences, Toronto, Canada
16Department of Psychology, Neuroscience & Behaviour, McMaster University, Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey B. Hall
16Department of Psychology, Neuroscience & Behaviour, McMaster University, Hamilton, Canada
17Imaging Research Centre, St. Joseph’s Healthcare Hamilton,Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond W. Lam
18University of British Columbia, Department of Psychiatry, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roumen Milev
19Queen’s University, Departments of Psychiatry and Psychology, and Providence Care Hospital, Kingston, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Müller
11Department of Psychiatry, University of Toronto, Toronto, Canada
12Institute of Medical Sciences, University of Toronto, Toronto, Canada
20Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada
21Department of Pharmacology & Toxicology, University of Toronto, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagar Parikh
22Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Soares
23Department of Psychiatry, Queen’s University, Providence Care, Kingston, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenda M. Macqueen
7University of Calgary, Cumming School of Medicine, Department of Psychiatry, Calgary, Canada
8Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen C. Strother
2Rotman Research Institute, Baycrest Health Sciences, Toronto, Canada
24University of Toronto, Department of Medical Biophysics, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea B. Protzner
1University of Calgary, Department of Psychology, Calgary, Canada
5Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada
8Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Clinical studies of major depression (MD) generally focus on group effects, yet inter-individual differences in brain function are increasingly recognised as important and may even impact effect sizes related to group effects. Here, we examine the magnitude of individual differences in relation to group differences that are commonly investigated (e.g., related to MD diagnosis and treatment response). Functional MRI data from 107 participants (63 female, 44 male) were collected at baseline, 2 and 8 weeks during which patients received pharmacotherapy (escitalopram, N=68), and controls (N=39) received no intervention. The unique contributions of different sources of variation were examined by calculating how much variance in functional connectivity was shared across all participants and sessions, within/across groups (patients vs controls, responders vs non-responders, female vs male participants), recording sessions and individuals. Individual differences and common connectivity across groups, sessions and participants contributed most to the explained variance (>95% across analyses). Group differences related to MD diagnosis, treatment response and biological sex made significant but small contributions (0.3-1.2%). High individual variation was present in cognitive control and attention areas, while low individual variation characterized primary sensorimotor regions. Group differences were much smaller than individual differences in the context of MD and its treatment. These results could be linked to the variable findings and difficulty translating research on MD to clinical practice. Future research should examine brain features with low and high individual variation in relation to psychiatric symptoms and treatment trajectories to explore the clinical relevance of the individual differences identified here.

Significance statement Studies on major depression often investigate differences in brain function between groups (e.g., those with/without a diagnosis) to better understand this prevalent condition. Our study examines such group differences in the context of similarities across and differences between individuals. We found strong common and individually unique features of brain network organization, relative to surprisingly subtle features of diagnosis, treatment success, and sex assigned at birth. From the overall explained variation in brain connectivity, about 50% was shared across everyone, while another 45% was unique to individuals. Only ∼5% could be attributed to group differences. Our results suggest that examining individual differences, and their potential clinical relevance, alongside group differences may bring us closer to improving clinical outcomes for major depression.

Footnotes

  • Benicio N. Frey has received grant/research support from Alternative Funding Plan Innovations Award, Brain and Behavior Research Foundation, Canadian Institutes of Health Research, Hamilton Health Sciences Foundation, J. P. Bickell Foundation, Ontario Brain Institute, Ontario Mental Health Foundation, Society for Women's Health Research, Teresa Cascioli Charitable Foundation, Eli Lilly and Pfizer, and has received consultant and/or speaker fees from AstraZeneca, Bristol-Myers Squibb, Canadian Psychiatric Association, CANMAT, Daiichi Sankyo, Lundbeck, Pfizer, Servier and Sunovion. Roumen V. Milev has received consulting and speaking honoraria from AbbVie, Allergan, Janssen, KYE, Lundbeck, Otsuka, and Sunovion, and research grants from CAN-BIND, CIHR, Janssen, Lallemand, Lundbeck, Nubiyota, OBI and OMHF. Sagar Parikh has been a consultant to Takeda, Bristol Myers Squibb, Lund- beck; has had a research contract with Assurex; has equity in Mensante. Raymond W. Lam has received speaker and consultant honoraria or research funds from AstraZeneca, Brain Canada, Bristol-Myers Squibb, the Canadian Institutes of Health Research (CIHR), the Canadian Network for Mood and Anxiety Treatments, the Canadian Psychiatric Association, Eli Lilly, Janssen, Lundbeck, Lundbeck Institute, Medscape, Otsuka, Pfizer, Servier, St. Jude Medical, Takeda, the University Health Network Foundation, Vancouver Coastal Health Research Institute, Allergan, Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, Healthy Minds Canada, Michael Smith Foundation for Health Research, MITACS, Myriad Neuroscience, Ontario Brain Institute, Otsuka, Unity Health, Viatris, and VGH-UBCH Foundation. Sidney H. Kennedy has received honoraria or research funds from Abbott, Alkermes, Allergan, Boehringer Ingelheim, Brain Canada, CIHR, Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund, Otsuka, Pfizer, Servier, Sunovion, Sun Pharmaceuticals, and holds stock in Field Trip Health. Daniel J. Müller has received consulting and speaking honoraria from Lundbeck and Genomind. Dr Soares has received consulting and speaking honoraria from Pfizer, Otsuka, Bayer, Eisai and research grants from CAN-BIND, CIHR, OBI, and SEAMO. Stephen C Strother is a senior Scientific Advisor and shareholder in ADMdx, Inc., which receives NIH funding, and during the period of this research, he had research grants from Brain Canada, Canada Foundation for Innovation (CFI), Canadian Institutes of Health Research (CIHR), and the Ontario Brain Institute in Canada. Other authors declare no competing financial interests.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Back to top
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
View Full Page PDF
Citation Tools
Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy
Gwen van der Wijk, Mojdeh Zamyadi, Signe Bray, Stefanie Hassel, Stephen R. Arnott, Benicio N. Frey, Sidney H. Kennedy, Andrew D. Davis, Geoffrey B. Hall, Raymond W. Lam, Roumen Milev, Daniel J. Müller, Sagar Parikh, Claudio Soares, Glenda M. Macqueen, Stephen C. Strother, Andrea B. Protzner
eNeuro 3 June 2024, ENEURO.0286-23.2024; DOI: 10.1523/ENEURO.0286-23.2024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy
Gwen van der Wijk, Mojdeh Zamyadi, Signe Bray, Stefanie Hassel, Stephen R. Arnott, Benicio N. Frey, Sidney H. Kennedy, Andrew D. Davis, Geoffrey B. Hall, Raymond W. Lam, Roumen Milev, Daniel J. Müller, Sagar Parikh, Claudio Soares, Glenda M. Macqueen, Stephen C. Strother, Andrea B. Protzner
eNeuro 3 June 2024, ENEURO.0286-23.2024; DOI: 10.1523/ENEURO.0286-23.2024
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Neural mechanisms of self-generated action sequences
  • Assessment of cell-type-specific excitatory synaptic strength in the dorsolateral striatum of goal-directed and habitual cocaine-seeking behavior
  • Heading and then saccades predict visual discrimination decisions in freely moving ferrets
Show more Research Article: New Research

Disorders of the Nervous System

  • Erbin Confers Neuroprotection Against Cerebral Ischemia-Reperfusion Injury in Mice via MAPK Pathway Inhibition
  • Deep Learning Discriminates Seizures from Normal Brain Oscillations in the Electroencephalogram of a Rat Model of Post-traumatic Epilepsy
  • A Multi-Network Approach Identifies Proteins Related to Dendritic Spines in Alzheimer’s Disease
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.